377.59 USD
-2.47 (-0.65%)
We assign a fundamental rating of 3 out of 10 to BRKRP. BRKRP was compared to 57 industry peers in the Life Sciences Tools & Services industry. There are concerns on the financial health of BRKRP while its profitability can be described as average. BRKRP is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year BRKRP was profitable.
- In the past year BRKRP had a positive cash flow from operations.
- Each year in the past 5 years BRKRP has been profitable.
- In the past 5 years BRKRP always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of -0.37%, BRKRP is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
- With a decent Return On Equity value of -0.97%, BRKRP is doing good in the industry, outperforming 63.16% of the companies in the same industry.
- BRKRP has a Return On Invested Capital of 4.01%. This is in the better half of the industry: BRKRP outperforms 66.67% of its industry peers.
- BRKRP had an Average Return On Invested Capital over the past 3 years of 9.30%. This is below the industry average of 13.75%.
- The 3 year average ROIC (9.30%) for BRKRP is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
- BRKRP's Profit Margin has declined in the last couple of years.
- BRKRP has a Operating Margin of 8.99%. This is in the better half of the industry: BRKRP outperforms 64.91% of its industry peers.
- BRKRP's Operating Margin has declined in the last couple of years.
- The Gross Margin of BRKRP (48.00%) is comparable to the rest of the industry.
- BRKRP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKRP is destroying value.
- The number of shares outstanding for BRKRP has been increased compared to 1 year ago.
- Compared to 5 years ago, BRKRP has less shares outstanding
- The debt/assets ratio for BRKRP is higher compared to a year ago.
2.2 Solvency
- BRKRP has an Altman-Z score of 10.06. This indicates that BRKRP is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of BRKRP (10.06) is better than 91.23% of its industry peers.
- A Debt/Equity ratio of 0.82 indicates that BRKRP is somewhat dependend on debt financing.
- BRKRP has a worse Debt to Equity ratio (0.82) than 77.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 10.06 |
ROIC/WACC0.37
WACC10.9%
2.3 Liquidity
- BRKRP has a Current Ratio of 1.85. This is a normal value and indicates that BRKRP is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.85, BRKRP is doing worse than 63.16% of the companies in the same industry.
- A Quick Ratio of 0.89 indicates that BRKRP may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.89, BRKRP is doing worse than 85.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
- BRKRP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
- BRKRP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
- BRKRP shows a small growth in Revenue. In the last year, the Revenue has grown by 6.10%.
- BRKRP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
- The Earnings Per Share is expected to grow by 5.58% on average over the next years.
- The Revenue is expected to grow by 3.38% on average over the next years.
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- BRKRP is valuated quite expensively with a Price/Earnings ratio of 188.79.
- BRKRP's Price/Earnings is on the same level as the industry average.
- When comparing the Price/Earnings ratio of BRKRP to the average of the S&P500 Index (27.47), we can say BRKRP is valued expensively.
- A Price/Forward Earnings ratio of 173.22 indicates a quite expensive valuation of BRKRP.
- BRKRP's Price/Forward Earnings is on the same level as the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. BRKRP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 188.8 | ||
| Fwd PE | 173.22 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as BRKRP.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 113.45 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)21.1
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
5. Dividend
5.1 Amount
- BRKRP has a yearly dividend return of 0.38%, which is pretty low.
- BRKRP's Dividend Yield is rather good when compared to the industry average which is at 0.09. BRKRP pays more dividend than 91.23% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, BRKRP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
- The dividend of BRKRP has a limited annual growth rate of 4.81%.
- BRKRP does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)4.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- BRKRP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
- The dividend of BRKRP is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
BRUKER CORP - BRKR 6 3/8 09/01/28
NASDAQ:BRKRP (1/16/2026, 8:00:01 PM)
377.59
-2.47 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners90.2%
Inst Owner ChangeN/A
Ins Owners26.95%
Ins Owner ChangeN/A
Market Cap57.37B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts79.09
Price Target400.26 (6%)
Short Float %0%
Short Ratio0.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)9.48%
PT rev (3m)3.42%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-24.3%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 188.8 | ||
| Fwd PE | 173.22 | ||
| P/S | 16.68 | ||
| P/FCF | N/A | ||
| P/OCF | 608.39 | ||
| P/B | 23.59 | ||
| P/tB | N/A | ||
| EV/EBITDA | 113.45 |
EPS(TTM)2
EY0.53%
EPS(NY)2.18
Fwd EY0.58%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY0.16%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)21.1
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 10.06 |
F-Score5
WACC10.9%
ROIC/WACC0.37
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year9.99%
EBIT Next 3Y11.38%
EBIT Next 5Y10.68%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP - BRKR 6 3/8 09/01/28 / BRKRP FAQ
What is the fundamental rating for BRKRP stock?
ChartMill assigns a fundamental rating of 3 / 10 to BRKRP.
What is the valuation status of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?
ChartMill assigns a valuation rating of 1 / 10 to BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP). This can be considered as Overvalued.
How profitable is BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?
BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) has a profitability rating of 5 / 10.
What is the expected EPS growth for BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?
The Earnings per Share (EPS) of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is expected to decline by -20.53% in the next year.
Can you provide the dividend sustainability for BRKRP stock?
The dividend rating of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is 2 / 10 and the dividend payout ratio is -96.62%.